Concepedia

Kristen Focht

KF

9

Publications

616

Citations

9

H-Index

2010

Active since

Affiliations

Pfizer (United States)(Current)

University of Virginia

University of Kansas

Virginia Commonwealth University

McMaster University

Kristen Focht is an author at Pfizer (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2010–2017

9

Publications

9

Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone

Steven G. Terra, Kristen Focht, Melanie J. Davies et al. · Diabetes Obesity and Metabolism · 2017 · 141 citations

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression

Sheldon Preskorn, Cecelia P. Kane, Kasia Lobello et al. · The Journal of Clinical Psychiatry · 2013 · 108 citations

Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

Anita H. Clayton, Susan G. Kornstein, Boadie W. Dunlop et al. · The Journal of Clinical Psychiatry · 2013 · 89 citations

Symptomatic and Functional Improvement in Employed Depressed Patients

Boadie W. Dunlop, Sujana Reddy, Lingfeng Yang et al. · Journal of Clinical Psychopharmacology · 2011 · 75 citations

Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers

Alice I. Nichols, Kristen Focht, Qin Jiang et al. · Clinical Drug Investigation · 2011 · 63 citations

, , +6

Rows per page

1–5 of 9